Bone Drug Reduces Odds for Breast Cancer’s Return: Study (HealthDay)
HealthDay – FRIDAY, June 3 (HealthDay News) — Early stage breast cancer patients can see their chances of the cancer’s return drop by 32 percent when the osteoporosis drug Zometa is added to regular hormone therapy for three years after surgery, Austrian researchers report.
View full post on Yahoo! News: Health News
Leave a Reply